Igg Elisa Laboratories manufactures the titer igg elisa commercial kits reagents distributed by Genprice. The Titer Igg Elisa Commercial Kits reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact IgG elisa. Other Titer products are available in stock. Specificity: Titer Category: Igg Group: Elisa Commercial
Canine True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Porcine True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Rat True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Sheep True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Mouse True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Rabbit True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Goat True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Elisa Commercial information
Sheep anti human PSA IgG fraction, high titer |
MBS135203-5x1mg |
MyBiosource |
5x1mg |
EUR 12835 |
QuickTiter Adenovirus Titer ELISA Kit |
MBS168539-2x96Assays |
MyBiosource |
2x96Assays |
EUR 835 |
Rabbit anti human prorenin IgG fraction, high titer |
MBS135264-01mg |
MyBiosource |
0.1mg |
EUR 500 |
Rabbit anti human prorenin IgG fraction, high titer |
MBS135264-1mg |
MyBiosource |
1mg |
EUR 3245 |
Sheep Anti Human PAI-1 IgG fraction - high titer |
MBS480218-01mg |
MyBiosource |
0.1mg |
EUR 460 |
Sheep Anti Human PAI-1 IgG fraction - high titer |
MBS480218-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1860 |
Goat Anti Rabbit PAI-1 IgG fraction - high titer |
MBS480235-01mg |
MyBiosource |
0.1mg |
EUR 770 |
Goat Anti Rabbit PAI-1 IgG fraction - high titer |
MBS480235-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3255 |
QuickTiter™ Adenovirus Titer ELISA Kit |
VPK-110 |
Cell Biolabs |
2 x 96 assays |
EUR 524 |
Description: Excepted Quantities |
High titer |
S501H |
101Bio |
100 µL ( > 1 x 10^8 IFU/mL ) |
EUR 1100 |
High titer |
S501HL |
101Bio |
200 µL ( > 1 x 10^8 IFU/mL ) |
EUR 1400 |
High titer |
S502H |
101Bio |
100 µL ( > 1 x 10^8 IFU/mL ) |
EUR 1100 |
Human Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0) |
RAS-T160 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
- The kit is developed for titer measurement of Anti-RSV-F0 Antibody IgG (Pre-Fusion glycoprotein F0) in Human serum.
|
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.To facilitate the RSV-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |
Mouse Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0) |
RAS-T161 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
- The kit is developed for titer measurement of Anti-RSV-F0 Antibody IgG (Pre-Fusion glycoprotein F0) in Mouse serum.
|
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.To facilitate the RSV-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |
Monkey Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0) |
RAS-T162 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
- The kit is developed for titer measurement of Anti-RSV-F0 Antibody IgG (Pre-Fusion glycoprotein F0) in Monkey serum.
|
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.To facilitate the RSV-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |
Mouse Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Post-Fusion glycoprotein F0) |
RAS-T168 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
- The kit is developed for titer measurement of Anti-RSV-F0 Antibody IgG (Post-Fusion glycoprotein F0) in Mouse serum.
|
Description: Most in vitro RSV neutralizing antibodies in human sera are directed against the prefusion conformation, but due to its instability the prefusion conformation has a propensity to prematurely refold into the stable postfusion conformation, both in solution and on the surface of the virions. An RSV F protein that has both high expression levels and maintains a stable prefusion conformation would, therefore, be a promising subunit vaccine candidate against RSV. To facilitate the RSV-related research, drug trials and vaccine development,a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |
Mouse Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Post-Fusion glycoprotein F0) |
RAS-T168-96tests |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
Description: Most in vitro RSV neutralizing antibodies in human sera are directed against the prefusion conformation, but due to its instability the prefusion conformation has a propensity to prematurely refold into the stable postfusion conformation, both in solution and on the surface of the virions. An RSV F protein that has both high expression levels and maintains a stable prefusion conformation would, therefore, be a promising subunit vaccine candidate against RSV. To facilitate the RSV-related research, drug trials and vaccine development,a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |